LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus-positive and -negative Merkel cell carcinoma.

    Torre-Castro, Juan / Rodríguez, Marta / Alonso-Alonso, Ruth / Mendoza Cembranos, María Dolores / Frutos Díaz-Alejo, Jesús / Rebollo-González, Marcos / Borregón, Jennifer / Nájera Botello, Laura / Mahillo-Fernández, Ignacio / Samimi, Mathab / Kervarrec, Thibault / Requena, Luis / Ángel Piris, Miguel

    The British journal of dermatology

    2024  

    Abstract: Background: Merkel cell carcinoma (MCC) is an aggressive malignant neuroendocrine tumour. There are two subsets of MCC, one related to Merkel cell polyomavirus (MCPyV) and the other to ultraviolet (UV) radiation. MCPyV-positive and MCPyV-negative MCCs ... ...

    Abstract Background: Merkel cell carcinoma (MCC) is an aggressive malignant neuroendocrine tumour. There are two subsets of MCC, one related to Merkel cell polyomavirus (MCPyV) and the other to ultraviolet (UV) radiation. MCPyV-positive and MCPyV-negative MCCs have been considered to be different tumours, since the former type harbours few DNA mutations and is not related to UV radiation, and the latter usually arises in sun-exposed areas and may be found in conjunction with other keratinocytic tumours, mostly squamous cell carcinomas. Two viral oncoproteins, large T antigen (LT, coded by MCPyV_gp3) and small T antigen (sT, coded by MCPyV_gp4), promote different carcinogenic pathways.
    Objectives: We hypothesized that the biological behaviours of MCPyV-positive and MCPyV-negative MCCs are different. We aimed to determine which genes are differentially expressed in MCPyV-positive and MCPyV-negative MCC, to describe the mutational burden and the most frequently mutated genes in the two MCC types, and to identify the clinical and molecular factors that may be related to patient survival.
    Methods: Ninety-two cases with a diagnosis of MCC were identified from the medical databases of the participating centres.To study gene expression, a customized panel of 172 genes was developed. Gene expression profiling was performed with nCounter Technology (NanoString Technologies, Seattle, WA, USA).For mutational studies, a customized panel of 26 genes was designed. Somatic single nucleotide variants (SNVs) were identified following the best practices GATK workflow for somatic mutations.
    Results: The expression of LT enabled the series to be divided into two groups, (LT-positive, n=55; LT-negative, n=37). Genes differentially expressed in LT-negative cases were related to epithelial differentiation, especially SOX9, or proliferation and cell cycle (MYC, CDK6), among others. Congruently, LT displayed lower expression in SOX9-positive cases, and differentially expressed genes in SOX9-positive cases were related to epithelial/squamous differentiation.In LT-positive cases, the mean SNV frequency was 4.3 per case, and 10 per case in LT-negative cases (p=0.03).The expression of SNAI1 (HR=1.046, 95% CI=1.007-1.086, p=0.021) and CDK6 (HR=1.049, 95% CI=1.020-1.080, p=0.001) were identified as risk factors in a multivariate survival analysis.
    Conclusions: Tumours with weak expression of LT tend to co-express genes related to squamous differentiation and cell cycle, and to have a higher mutational burden. These findings are congruent with those of earlier studies.
    Language English
    Publishing date 2024-01-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 80076-4
    ISSN 1365-2133 ; 0007-0963
    ISSN (online) 1365-2133
    ISSN 0007-0963
    DOI 10.1093/bjd/ljae033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: NanoString analysis of mycosis fungoides reveals individual molecular identity.

    Alonso-Alonso, Ruth / Rodríguez, Marta / García-Díaz, Nuria / Tomás-Roca, Laura / Borregón, Jennifer / Cabezuelo-Rodríguez, Marta / Rebollo-González, Marcos / Gallego-Manzano, Luis / Cereceda, Laura / Rodriguez-Pinilla, Socorro María / Córdoba, Raúl / Fernando García, Juan / Torre-Castro, Juan / García-Álvarez, Carmen M / Del Mar Onteniente Gomis, María / Rivera-Díaz, Raquel / Rodriguez-Peralto, José Luis / Vaqué, José Pedro / Ortiz-Romero, Pablo Luis /
    Piris, Miguel Á

    The British journal of dermatology

    2023  Volume 188, Issue 6, Page(s) 812–814

    MeSH term(s) Humans ; Mycosis Fungoides/diagnosis ; Mycosis Fungoides/genetics ; Skin Neoplasms/genetics
    Language English
    Publishing date 2023-03-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 80076-4
    ISSN 1365-2133 ; 0007-0963
    ISSN (online) 1365-2133
    ISSN 0007-0963
    DOI 10.1093/bjd/ljad061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers.

    Rodríguez, Marta / Alonso-Alonso, Ruth / Tomás-Roca, Laura / Rodríguez-Pinilla, Socorro M / Manso-Alonso, Rebeca / Cereceda, Laura / Borregón, Jennifer / Villaescusa, Teresa / Córdoba, Raúl / Sánchez-Beato, Margarita / Fernández-Miranda, Ismael / Betancor, Isabel / Bárcena, Carmen / García, Juan F / Mollejo, Manuela / García-Cosio, Mónica / Martin-Acosta, Paloma / Climent, Fina / Caballero, Dolores /
    de la Fuente, Lorena / Mínguez, Pablo / Kessler, Linda / Scholz, Catherine / Gualberto, Antonio / Mondéjar, Rufino / Piris, Miguel A

    Blood advances

    2021  Volume 5, Issue 24, Page(s) 5588–5598

    Abstract: Peripheral T-cell lymphoma (PTCL) is a clinically aggressive disease, with a poor response to therapy and a low overall survival rate of approximately 30% after 5 years. We have analyzed a series of 105 cases with a diagnosis of PTCL using a customized ... ...

    Abstract Peripheral T-cell lymphoma (PTCL) is a clinically aggressive disease, with a poor response to therapy and a low overall survival rate of approximately 30% after 5 years. We have analyzed a series of 105 cases with a diagnosis of PTCL using a customized NanoString platform (NanoString Technologies, Seattle, WA) that includes 208 genes associated with T-cell differentiation, oncogenes and tumor suppressor genes, deregulated pathways, and stromal cell subpopulations. A comparative analysis of the various histological types of PTCL (angioimmunoblastic T-cell lymphoma [AITL]; PTCL with T follicular helper [TFH] phenotype; PTCL not otherwise specified [NOS]) showed that specific sets of genes were associated with each of the diagnoses. These included TFH markers, cytotoxic markers, and genes whose expression was a surrogate for specific cellular subpopulations, including follicular dendritic cells, mast cells, and genes belonging to precise survival (NF-κB) and other pathways. Furthermore, the mutational profile was analyzed using a custom panel that targeted 62 genes in 76 cases distributed in AITL, PTCL-TFH, and PTCL-NOS. The main differences among the 3 nodal PTCL classes involved the RHOAG17V mutations (P < .0001), which were approximately twice as frequent in AITL (34.09%) as in PTCL-TFH (16.66%) cases but were not detected in PTCL-NOS. A multivariate analysis identified gene sets that allowed the series of cases to be stratified into different risk groups. This study supports and validates the current division of PTCL into these 3 categories, identifies sets of markers that can be used for a more precise diagnosis, and recognizes the expression of B-cell genes as an IPI-independent prognostic factor for AITL.
    MeSH term(s) Humans ; Immunoblastic Lymphadenopathy ; Lymphoma, T-Cell, Peripheral/diagnosis ; Lymphoma, T-Cell, Peripheral/genetics ; Mutation ; Phenotype ; Prognosis
    Language English
    Publishing date 2021-09-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2915908-8
    ISSN 2473-9537 ; 2473-9529
    ISSN (online) 2473-9537
    ISSN 2473-9529
    DOI 10.1182/bloodadvances.2021005171
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Subcutaneous panniculitis-like T-cell lymphoma, lupus erythematosus profundus, and overlapping cases: molecular characterization through the study of 208 genes.

    Machan, Salma / Rodríguez, Marta / Alonso-Alonso, Ruth / Manso, Rebeca / Pérez-Buira, Sandra / Borregón, Jennifer / Rodríguez-Peralto, José Luis / Cerroni, Lorenzo / Haro, Rosario / García, Candelaria / García Toro, Enrique / Estrach, Teresa / García-Herrera, Adriana / Ferrer, Berta / González-Cruz, Carlos / Segues, Nerea / Afonso-Martin, Juan Luis / Peñate, Yeray / Monteagudo, Carlos /
    Limeres-Gonzalez, Miguel Ángel / González-Núñez, María Ángeles / Torres, Maria Ángeles Torres-Nieto / Cereceda, Laura / Córdoba, Raúl / Piris, Miguel Ángel / Requena, Luis / María Rodríguez-Pinilla, Socorro

    Leukemia & lymphoma

    2021  Volume 62, Issue 9, Page(s) 2130–2140

    Abstract: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare cytotoxic cutaneous lymphoma. Differential diagnosis with lupus erythematosus panniculitis (LEP) can be challenging and overlapping cases have been described. In this study, we investigate ... ...

    Abstract Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare cytotoxic cutaneous lymphoma. Differential diagnosis with lupus erythematosus panniculitis (LEP) can be challenging and overlapping cases have been described. In this study, we investigate whether gene expression profiling may or not identify markers that can be used to improve our understanding of the disease and to make a precise differential diagnosis. SPTCL, LEP, and overlapping cases were analyzed using a customized NanoString platform including 208 genes related to T-cell differentiation, stromal signatures, oncogenes, and tumor suppressor genes. Gene expression unsupervised analysis of the samples differentiated SPTCL from LEP samples. Most overlapping cases were clustered with LEP cases. Differentially expressed genes were observed when comparing SPTCL with LEP cases; and overlapping with LEP cases. Gene set enrichment analysis recognized gene sets defining each group. In conclusion, SPTCL and LEP have distinctive molecular profiles and the molecular background of overlapping cases more closely resembles LEP.
    MeSH term(s) Diagnosis, Differential ; Humans ; Immunohistochemistry ; Lymphoma, T-Cell/diagnosis ; Lymphoma, T-Cell/genetics ; Panniculitis/diagnosis ; Panniculitis/genetics ; Panniculitis, Lupus Erythematosus/diagnosis ; Panniculitis, Lupus Erythematosus/genetics
    Language English
    Publishing date 2021-05-08
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1042374-6
    ISSN 1029-2403 ; 1042-8194
    ISSN (online) 1029-2403
    ISSN 1042-8194
    DOI 10.1080/10428194.2021.1901098
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy.

    Rodríguez, Marta / Alonso-Alonso, Ruth / Fernández-Miranda, Ismael / Mondéjar, Rufino / Cereceda, Laura / Tráscasa, Álvaro / Antonio-Da Conceiçao, Anabel / Borregón, Jennifer / Gato, Lucía / Tomás-Roca, Laura / Bárcena, Carmen / Iglesias, Begoña / Climent, Fina / González-Barca, Eva / Camacho, Francisca Inmaculada / Mayordomo, Émpar / Olmedilla, Gabriel / Gómez-Prieto, Pilar / Castro, Yolanda /
    Serrano-López, Juana / Sánchez-García, Joaquín / Montes-Moreno, Santiago / García-Cosío, Mónica / Martín-Acosta, Paloma / García, Juan F / Planelles, María / Quero, Cristina / Provencio, Mariano / Mahíllo-Fernández, Ignacio / Rodríguez-Pinilla, Socorro M / Derenzini, Enrico / Pileri, Stefano / Sánchez-Beato, Margarita / Córdoba, Raúl / Piris, Miguel A

    EJHaem

    2022  Volume 3, Issue 3, Page(s) 722–733

    Abstract: Diffuse large B-cell lymphoma (DLBCL), the most frequent non-Hodgkin's lymphoma subtype, is characterized by strong biological, morphological, and clinical heterogeneity, but patients are treated with immunochemotherapy in a relatively homogeneous way. ... ...

    Abstract Diffuse large B-cell lymphoma (DLBCL), the most frequent non-Hodgkin's lymphoma subtype, is characterized by strong biological, morphological, and clinical heterogeneity, but patients are treated with immunochemotherapy in a relatively homogeneous way. Here, we have used a customized NanoString platform to analyze a series of 197 homogeneously treated DLBCL cases. The platform includes the most relevant genes or signatures known to be useful for predicting response to R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) in DLBCL cases. We generated a risk score that combines the International Prognostic Index with cell of origin and double expression of
    Language English
    Publishing date 2022-05-03
    Publishing country United States
    Document type Journal Article
    ISSN 2688-6146
    ISSN (online) 2688-6146
    DOI 10.1002/jha2.457
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top